Correlation - European Harm Reduction Network

What Correlation - European Harm Reduction Network does

Correlation - European Harm Reduction Network (C-EHRN) is a European civil society network and centre of expertise established in 2004 in Amsterdam, hosted by Foundation De Regenboog Groep (FRG). It unites community-based organisations, research institutes, health providers, and policymakers across more than 30 countries in the WHO Europe Region, reaching beneficiaries including people who use drugs, people experiencing homelessness, people living with HIV/HCV, people in prison, migrants, sex workers, women, and youth. The network's primary operational artefacts are the C-EHRN Monitoring Dashboard (annual city-level data on harm reduction service availability, accessibility, quality, equity, and human rights), the Learn Addiction e-learning platform, the Behind the Walls prison harm reduction toolkit, and the ENDCR European Network of Drug Consumption Rooms. C-EHRN also convenes the biennial European Harm Reduction Conference and maintains formal participation in EU civil society forums on drugs and on HIV/AIDS, viral hepatitis, and tuberculosis.

C-EHRN operates as a grant-funded non-governmental network rather than a technology product company; its principal offerings are data, publications, capacity-building resources, and advocacy infrastructure. Underlying assets include the Focal Point monitoring network (40+ reference organisations across Europe), the membership base (100+ organisations), and curated datasets on harm reduction services collected annually since 2018 that complement official EU monitoring. Distribution is non-commercial: publications, toolkits, and reports are published openly on correlation-net.org, while field-level implementation is carried out by member organisations and Focal Points.

The business model is project-based grant funding. Revenue streams include EU grants channelled through programmes such as EU4Health, Erasmus+, HaDEA, the EUDA (successor to EMCDDA), and the EU Justice Programme, plus philanthropic grant support from Gilead Sciences Europe Ltd. A small secretariat of approximately 13 staff in Amsterdam coordinates the network under director Katrin Schiffer; an Advisory Committee elected by members, a Scientific Advisory Board, and Expert Networks provide governance. C-EHRN does not sell products or services and has no pricing structure; sustainability is contingent on continued public-sector and philanthropic funding for harm reduction, drug policy, and public health priorities.

Name

Correlation - European Harm Reduction Network

Legal name

Correlation – European Harm Reduction Network

Website

https://correlation-net.org

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

Correlation - European Harm Reduction Network (C-EHRN) is a European civil society network and centre of expertise uniting 100+ harm reduction organisations across 30+ countries, delivering monitoring data, capacity-building resources, and advocacy for evidence-based drug policy.

Ownership category

akta.pro rank

Product category

Harm Reduction Services / Civil Society Network

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Social Services (8300), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM)

akta.pro secondary industries

Health Systems Strengthening & Universal Health Coverage (UHC) Partnerships (HLAJAOAL), Non-Communicable Disease Prevention & Chronic Disease Programs (BPAIAJAI)

Keywords

• Harm reduction network
• Drug policy advocacy
• Civil society monitoring
• Substance use research
• Community health services

Headquarters

HQ city

Amsterdam, Noord-Holland

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. European Union Funding: C-EHRN is co-funded by the European Union, receiving grants for its network operations and thematic projects (EU4Health, Erasmus+, HaDEA, EUDA, Justice Programme). Projects include C-EHRN Monitoring, ENDCR, EU-COMP, CAPABLE, BOOST, CORE, DRUG-PREP, SO-PREP, SEMID-EU, FENIQS-EU, Learn Addiction, and others.
2. Philanthropic Funding: C-EHRN acknowledges financial grant support from Gilead Sciences Europe Ltd. for specific project activities.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels10 records

Core offering

Correlation – European Harm Reduction Network (C-EHRN) is a civil society network and centre of expertise that unites harm reduction organisations, researchers and policymakers across the WHO Europe Region to advance evidence-based drug policy and practice. It delivers annual city-level monitoring data on harm reduction services, capacity-building tools, e-learning, advocacy kits, and a biennial European Harm Reduction Conference. Resources are distributed free of charge to member organisations and the broader harm reduction community.

Product overview

Correlation - European Harm Reduction Network (C-EHRN) is a civil society network organization rather than a traditional product company. Its primary offerings include the C-EHRN Monitoring Dashboard for tracking harm reduction services across European cities, the Learn Addiction E-Learning Platform for professional development in substance use fields, and various toolkits including the Behind the Walls prison harm reduction toolkit. The network also publishes annual monitoring reports, thematic publications, and provides resources through its member organizations across Europe.

Differentiator

Problem solved

Functional benefit

Brands

• C-EHRN Monitoring: Annual civil society-led monitoring of harm reduction services across Europe, providing city-level data on service availability and gaps
• ENDCR - European Network of Drug Consumption Rooms
• European Hepatitis C Initiative

Quantifiable outcome

• Annual monitoring reports published since 2018 covering harm reduction service availability, accessibility, quality, equity, and human rights across 30+ European cities.
• +2 more outcomes

Named customers17 records

Segments8 records

Ideal customer profiles2 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

24 partnerships are on record, tiered core and major.

• OKANA (Greece)coreStrategic or Co-development Partner · 1 January 2025Partner in ENDCR technical meetings on drug consumption rooms, co-organised with OKANA and EMCDDA/EUDA in Athens in June 2024.
• European Forum for Urban Security (EFUS)majorStrategic or Co-development Partner · 1 January 2024C-EHRN partners with EFUS as coordinator of the CAPABLE project on strengthening local responses to youth involvement in drug markets.
• International Network of People Who Use Drugs (INPUD)coreStrategic or Co-development Partner · 1 January 2024Collaborates on peer involvement projects, monitoring activities, and advocacy for meaningful involvement of people who use drugs in policy.
• Drug Policy Network South East Europe (DPNSEE)majorStrategic or Co-development Partner · 1 January 2024Partner in BOOST and civil society monitoring projects, contributing to drug policy advocacy in Southeast Europe.
• European Harm Reduction International (EHRI)majorStrategic or Co-development Partner · 1 January 2024Collaborates with EHRI on harm reduction advocacy, monitoring, and international knowledge exchange.
• SCAN / Charles UniversitycoreStrategic or Co-development Partner · 1 January 2023Partner in the EU-COMP project for developing harmonised training frameworks for the EU addiction workforce.
• European Federation of Addiction Societies (EUFAS)coreStrategic or Co-development Partner · 1 January 2023Partner in EU-COMP, contributing to competence-building materials and professional development for the substance use workforce in Europe.
• European Network of People Who Use Drugs (EuroNPUD)coreStrategic or Co-development Partner · 1 January 2023Partner in EU-COMP, ensuring meaningful involvement of people who use drugs in curriculum development and workforce training.
• European Union Drugs Agency (EUDA)coreStrategic or Co-development Partner · 1 January 2023EUDA funds and partners on EU-COMP and co-organises technical meetings on drug consumption rooms with ENDCR/C-EHRN. EUDA is the successor to the EMCDDA.
• CAPABLE Partners (EFUS, GI-TOC, Ghent University, Genk, Rotterdam, Lisbon, Cali)majorStrategic or Co-development Partner · 1 January 2023Erasmus+ project on youth involvement in drug markets, bringing together harm reduction, youth, prevention services, and police stakeholders. C-EHRN partners with EFUS (coordinator), GI-TOC, and Ghent University.
• CORE Project Partners (24 partners, 16 EU Member States)majorStrategic or Co-development Partner · 1 January 2023EU4Health-funded project (January 2023 – December 2025) involving 24 partners across 16 EU Member States, aimed at reducing inequalities in HIV, TB, and viral hepatitis responses by promoting community responses.
• BOOST Project PartnersmajorStrategic or Co-development Partner · 1 January 2023EU4Health-funded project coordinated by C-EHRN, involving partners such as ABD, DPNSEE, Fondazione Villa Maraini, EHRA, EuroNPUD, IGTP, ISGlobal. Aims to enhance community-based HIV, HCV, and STI services.
• SEMID-EU Partners (Mainline, Gaia Paris, Fixpunkt, ISGlobal, Positive Voice, Ghent University)majorStrategic or Co-development Partner · 1 January 2023EU Justice Programme-funded project addressing migration and drug use in the EU, led by Mainline. C-EHRN collaborates with Gaia Paris, Fixpunkt, ISGlobal, Positive Voice, and Ghent University.
• European AIDS Treatment Group (EATG)coreStrategic or Co-development Partner · 1 January 2023Partner in CORE project and civil society forums on HIV, hepatitis, and TB. Collaborates on policy dialogue and community response to health inequalities.
• Eurasian Harm Reduction Association (EHRA)coreStrategic or Co-development Partner · 1 January 2023Partner in BOOST and other projects, contributing to harm reduction advocacy and capacity building across Europe.
• FEANTSA (European Federation of National Organisations Working with the Homeless)majorStrategic or Co-development Partner · 1 January 2023Partner in HR4Homelessness project and HR4Homelessness Resource Hub and Good Practice Collection, promoting harm reduction in homeless services.
• Trans European Drug Information Network (TEDI)coreStrategic or Co-development Partner · 1 January 2023TEDI contributes to drug checking trends monitoring, with C-EHRN-TEDI Monitoring reports published on European Drug Checking Trends.
• Global Initiative against Transnational Organised Crime (GI-TOC)majorStrategic or Co-development Partner · 1 January 2023Partner in CAPABLE project, contributing expertise on organised crime and drug market responses.
• Nobody Left Outside (NLO) InitiativemajorStrategic or Co-development Partner · 1 January 2023Collective of organisations representing marginalised communities (homeless, LGTBI, people who use drugs, prisoners, sex workers, migrants) working to improve healthcare access. C-EHRN is a participant.
• FENIQS-EU Partners (Ghent University, University of Zagreb, Claude Bernard University of Lyon, IREFREA, EUFAS, Euro-TC)majorStrategic or Co-development Partner · 1 January 2021Project on implementing Quality Standards in drug demand reduction throughout the EU, led by University of Gent. C-EHRN contributed to identifying good practice examples and developing implementation toolkits.
• Gent UniversitycoreStrategic or Co-development Partner · 1 January 2018Academic partner in the C-EHRN Monitoring (since 2018) and EU-COMP project. Contributes scientific expertise to monitoring activities and curriculum development for the addiction workforce.
• European Commission - Civil Society Forum on DrugscoreStrategic or Co-development Partner · 1 January 2018C-EHRN participates in the Civil Society Forum on Drugs, an expert group of the European Commission established in 2007 to facilitate NGO participation in drug policy development.
• EU HIV/AIDS, Viral Hepatitis and Tuberculosis Civil Society ForumcoreStrategic or Co-development Partner · 1 January 2017C-EHRN participates in this forum established by the European Commission, extended in 2017 to include viral hepatitis and TB organisations.
• Foundation De Regenboog Groep (FRG)coreStrategic or Co-development Partner · 1 January 2012C-EHRN is hosted by FRG in Amsterdam. FRG is a non-governmental low-threshold service organisation providing harm reduction services to people who use drugs. The C-EHRN director also serves as Head of FRG's International Department.

Scale indicators5 records

Recent moves7 records

Expansion highlights7 records

Broad incumbents

• Drug Policy Alliance: US-based drug policy reform organisation with global advocacy reach. Comparable mission and advocacy orientation to C-EHRN but operates at significantly larger scale, is US-centric rather than Europe-focused, and combines advocacy with sizeable grant-making activity.

Direct peers

• Harm Reduction International: Global civil society organisation dedicated to reducing drug-related harms. Closest peer to C-EHRN in mission, advocacy orientation, and convening role; operates at global level rather than Europe-only and does not run the same civil-society-led city monitoring programme.
• Eurasian Harm Reduction Association (EHRA): Regional harm reduction network covering Eastern Europe and Central Asia, with overlapping membership, partner organisations, and EU-funded project collaborations with C-EHRN (e.g., BOOST). Directly comparable in scope, governance, and donor base, but with a different geographic remit.
• International Network of People Who Use Drugs (INPUD): Global peer-run network advocating for the rights and health of people who use drugs. C-EHRN collaborates with INPUD on peer involvement projects and monitoring; both share a civil-society, advocacy-led operating model at the intersection of drug policy and human rights.
• European AIDS Treatment Group (EATG): European civil society organisation of people living with HIV/AIDS and their advocates. C-EHRN is a partner in the CORE project and the EU HIV/AIDS, Viral Hepatitis and TB Civil Society Forum; comparable in being a pan-European membership-based health advocacy network.
• European Network of People Who Use Drugs (EuroNPUD): European regional peer network of people who use drugs, listed as a partner in C-EHRN's EU-COMP project. Operates a comparable membership and advocacy model focused on meaningful involvement of drug users in European drug policy.
• Release (UK): UK-based drugs charity providing advice, advocacy, and harm reduction services, listed as a C-EHRN member organisation. Comparable in mission and harm-reduction service orientation, though UK-focused rather than pan-European.
• Drug Policy Network South East Europe (DPNSEE): Regional civil society network coordinating drug policy and harm reduction advocacy across South East Europe. Listed as a C-EHRN project partner (BOOST, monitoring), with comparable membership-based structure and policy-focused activities.

Emerging players

• European Public Health Alliance (EPHA): European civil society alliance working on public health policy across multiple verticals including harm reduction, infectious disease, and health systems. Comparable in EU-policy advocacy model but covers a broader health portfolio rather than specialising in harm reduction.

Others

• European Union Drugs Agency (EUDA): EU agency (formerly EMCDDA) that funds C-EHRN projects and co-produces technical outputs. Not a civil society peer but a key funder and counterpart; relevant for benchmarking C-EHRN's monitoring and policy work against the EU's official drug data infrastructure.

Market position

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xbsky.app/profile/correlationnet.bsky.social
• Facebookfacebook.com/CorrelationNet
• LinkedInlinkedin.com/company/correlation-network
• Instagraminstagram.com/correlationnet?igsh=MTRzYnJza2xqd3U5eA==

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Correlation - European Harm Reduction Network